ClinicalTrials.Veeva

Menu

Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors

C

Canadian Center for Functional Medicine

Status and phase

Completed
Phase 2

Conditions

People Who Are Overweight or Obesity

Treatments

Dietary Supplement: cellulose and soybean oil
Dietary Supplement: soluble fibre complex and medium chain triglycerides

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to investigate whether the addition of capsules containing soluble fibre complex emulsified with medium chain triglycerides and taken before with meals will lead to a significant amount of weight loss, reduced glycemic volatility and diminished cardio metabolic risk factors in overweight and obese individuals when compared to a placebo control.

We believe that those participants taking 3-6 capsules per day of the treatment capsules over a 14 week period will loose a significant amount of weight compared to the placebo group.

Enrollment

138 patients

Sex

All

Ages

20 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • BMI 27 - 35 kg/m2

Exclusion criteria

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

138 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
cellulose and soybean oil
Treatment:
Dietary Supplement: cellulose and soybean oil
Intervention
Experimental group
Description:
soluble fibre complex and medium chain triglycerides
Treatment:
Dietary Supplement: soluble fibre complex and medium chain triglycerides

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems